No Data
Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics, A New Biotherapeutic Class
After Losing 23% in the Past Year, Foghorn Therapeutics Inc. (NASDAQ:FHTX) Institutional Owners Must Be Relieved by the Recent Gain
Express News | Foghorn Therapeutics Says Flagship Pioneering Raised $3.6B To To Support The Creation And Development Of An Estimated 25 Breakthrough Companies In Human Health
Flagship Pioneering Raises $3.6 Billion to Fuel Breakthrough Innovations That Transform Human Health and Sustainability
Flagship Pioneering Expands Leadership Team With Key Appointments and Promotions
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity Under Strategic Partnership With Pfizer